Answers are grounded in this paper and cite their sources.
Reveals the regulatory roles of long non-coding RNAs in methotrexate pharmacology, suggesting future research implications.
lncRNAs function as context-dependent modulators of MTX PK/PD processes rather than primary drug targets. Current evidence is heterogeneous, future studies integrating functional genomics, PK measurements, and prospective clinical validation are required to establish lncRNAs as predictive biomarkers or therapeutic targets in MTX precision pharmacology.
No takes yet. Share an insight, caveat, or question.
Guzmán-Martín et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: